Clinical Trial Update: CAT-VHL Exploring the Role of Carbonic Anhydrase IX as Diagnostic and Theranostic Target in Von-Hippel Lindau Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial CAT-VHL is investigating carbonic anhydrase IX as a diagnostic and theranostic target in Von Hippel-Lindau disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Hippel-lindau Disease

Snippet

Sponsor: IRCCS Ospedale San Raffaele | Conditions: VHL - Von Hippel-Lindau Syndrome | Phase 2 | Status: RECRUITING